US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 09:36:49 Source：Stellar Signals news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Trump visits Minnesota after son Barron's Florida high school graduation
- Next：Georgia QB Jaden Rashada sues Florida coach, others over failed $14M NIL deal
Related articles
- Report says China is accelerating the forced urbanization of rural Tibetans
- Box office: ‘Challengers’ scores with $15 million in ticket sales
- In unusual push, funders band together to get out grants around election work 'early'
- Paris Olympic athletes to feast on freshly baked bread, select cheeses and plenty of veggie options
- Germany far
- In unusual push, funders band together to get out grants around election work 'early'
- Former Italian foreign minister convicted for role in sale of Monte Carlo apartment
- Portuguese
- Poland arrests sabotage suspects and warns of potential hostile acts by Russia
- Immigrant's $1.3B Powerball win spotlights the Iu Mien community
- Clark signs deal with Wilson Sporting Goods for signature line
- Ralph Lauren goes minimal for latest fashion show, with muted tones and a more intimate setting
- India recalls Rishabh Pant for T20 World Cup after near
- EDEN CONFIDENTIAL: Prince Harry's army friend JJ Chalmers urges Kate to talk about cancer
- Protesters against war in Gaza interrupt Blinken repeatedly in the Senate
- South African boxer Dingaan Thobela, 'The Rose of Soweto,' dies aged 57
- Moment serial dine
- Scammers stole more than $3.4 billion from older Americans last year, an FBI report says
- Tagovailoa misses Dolphins' OTA day to attend Saban's charity golf tournament
- Derrick White scores 38, Celtics top Heat 102
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Stellar Signals news portal sitemap